149 related articles for article (PubMed ID: 22766732)
1. Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.
Wallon D; Rovelet-Lecrux A; Deramecourt V; Pariente J; Auriacombe S; Le Ber I; Schraen S; Pasquier F; Campion D; Hannequin D
J Alzheimers Dis; 2012; 32(1):19-22. PubMed ID: 22766732
[TBL] [Abstract][Full Text] [Related]
2. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
[TBL] [Abstract][Full Text] [Related]
8. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases.
van Rheenen W; van Blitterswijk M; Huisman MH; Vlam L; van Doormaal PT; Seelen M; Medic J; Dooijes D; de Visser M; van der Kooi AJ; Raaphorst J; Schelhaas HJ; van der Pol WL; Veldink JH; van den Berg LH
Neurology; 2012 Aug; 79(9):878-82. PubMed ID: 22843265
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.
Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Otto M; Kornhuber J; Rüther E; Wiltfang J
Dement Geriatr Cogn Disord; 2011; 31(1):37-44. PubMed ID: 21135556
[TBL] [Abstract][Full Text] [Related]
10. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Daoud H; Suhail H; Sabbagh M; Belzil V; Szuto A; Dionne-Laporte A; Khoris J; Camu W; Salachas F; Meininger V; Mathieu J; Strong M; Dion PA; Rouleau GA
Arch Neurol; 2012 Sep; 69(9):1159-63. PubMed ID: 22964911
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.
Galimberti D; Fenoglio C; Serpente M; Villa C; Bonsi R; Arighi A; Fumagalli GG; Del Bo R; Bruni AC; Anfossi M; Clodomiro A; Cupidi C; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Bessi V; Marcone A; Cerami C; Cappa SF; Filippi M; Agosta F; Magnani G; Comi G; Franceschi M; Rainero I; Giordana MT; Rubino E; Ferrero P; Rogaeva E; Xi Z; Confaloni A; Piscopo P; Bruno G; Talarico G; Cagnin A; Clerici F; Dell'Osso B; Comi GP; Altamura AC; Mariani C; Scarpini E
Biol Psychiatry; 2013 Sep; 74(5):384-91. PubMed ID: 23473366
[TBL] [Abstract][Full Text] [Related]
12. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
[TBL] [Abstract][Full Text] [Related]
13. Screening for C9orf72 Expansion Mutation in Serbian Patients with Early-Onset Dementia.
Mandic-Stojmenovic G; Stefanova E; Dobricic V; Novakovic I; Stojkovic T; Jesic A; Kostic V
Dement Geriatr Cogn Disord; 2015; 40(5-6):358-65. PubMed ID: 26401819
[TBL] [Abstract][Full Text] [Related]
14. Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Boulanghien J; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Perret-Liaudet A; Touchon J; Lehmann S
J Alzheimers Dis; 2011; 26(3):553-63. PubMed ID: 21709372
[TBL] [Abstract][Full Text] [Related]
15. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan.
Tsai CP; Soong BW; Tu PH; Lin KP; Fuh JL; Tsai PC; Lu YC; Lee IH; Lee YC
Neurobiol Aging; 2012 Sep; 33(9):2232.e11-2232.e18. PubMed ID: 22673113
[TBL] [Abstract][Full Text] [Related]
16. C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration.
Gómez-Tortosa E; Gallego J; Guerrero-López R; Marcos A; Gil-Neciga E; Sainz MJ; Díaz A; Franco-Macías E; Trujillo-Tiebas MJ; Ayuso C; Pérez-Pérez J
Neurology; 2013 Jan; 80(4):366-70. PubMed ID: 23284068
[TBL] [Abstract][Full Text] [Related]
17. [Biomarkers in spinal fluid of patients with dementia].
Skogseth RE; Fladby T; Mulugeta E; Aarsland D
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948
[TBL] [Abstract][Full Text] [Related]
18. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
[TBL] [Abstract][Full Text] [Related]
19. Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.
Arighi A; Fumagalli GG; Jacini F; Fenoglio C; Ghezzi L; Pietroboni AM; De Riz M; Serpente M; Ridolfi E; Bonsi R; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2012; 31(2):447-52. PubMed ID: 22571983
[TBL] [Abstract][Full Text] [Related]
20. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study.
Benussi L; Rossi G; Glionna M; Tonoli E; Piccoli E; Fostinelli S; Paterlini A; Flocco R; Albani D; Pantieri R; Cereda C; Forloni G; Tagliavini F; Binetti G; Ghidoni R
J Alzheimers Dis; 2014; 38(4):799-808. PubMed ID: 24064469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
